Hypermethylation of gene promoters in hematological neoplasia
about
sameAs
Epigenetic dysregulation of Wnt signaling pathway in multiple myelomaEpigenetic inactivation of the miR-124-1 in haematological malignancies.Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and SHP1 in Philadelphia-negative myeloproliferative neoplasmUpdated survivals and prognostic factor analysis in myeloma treated by a staged approach use of bortezomib/thalidomide/dexamethasone in transplant eligible patients.Epigenetic inactivation of the hsa-miR-203 in haematological malignancies.Gene silencing of the p15/INK4B cell-cycle inhibitor by hypermethylation: an early or later epigenetic alteration in myelodysplastic syndromes?A seven-gene CpG-island methylation panel predicts breast cancer progressionThe role of DNA hypermethylation in the pathogenesis and prognosis of acute lymphoblastic leukemia.Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms.Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patientsAberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma.Epigenetic dysregulation of the death-associated protein kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in multiple myeloma.The silence of the genes: epigenetic disturbances in haematopoietic malignancies.Is targeted therapy feasible in acute myelogenous leukemia?Adverse prognostic impact of CDKN2B hyper-methylation in acute promyelocytic leukemia.Epigenetic inactivation of the MIR129-2 in hematological malignancies.Methylation in esophageal carcinogenesis.Gene silencing by DNA methylation in haematological malignancies.The use of hypomethylating agents in the treatment of hematologic malignancies.Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.Dysregulation of the C/EBPalpha differentiation pathway in human cancer.Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias.Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.Methylation of promoter of RBL1 enhances the radioresistance of three dimensional cultured carcinoma cellsDNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family.DNA methylation of microRNA genes in multiple myeloma.The role of decitabine for the treatment of acute myeloid leukemia.Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies.Epigenetic regulation of hypoxia inducible factor in diseases and therapeutics.Targeting FLT3 to treat leukemia.Essential role of caspase-8 in p53/p73-dependent apoptosis induced by etoposide in head and neck carcinoma cells.Eicosapentaenoic acid demethylates a single CpG that mediates expression of tumor suppressor CCAAT/enhancer-binding protein delta in U937 leukemia cellsDNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.DNA methylation of tumor suppressor protein-coding and non-coding genes in multiple myeloma.Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma.Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia.Identification of GLIPR1 tumor suppressor as methylation-silenced gene in acute myeloid leukemia by microarray analysis.Epigenetic inactivation of the miR-34a in hematological malignancies.Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies.
P2860
Q28249838-C53E8E1D-1DF9-4C4E-A8E9-741939BD6071Q31008825-B14D8234-F2B7-48CE-AD04-50BA08CCFE8EQ34154772-FE1C4EEF-0A0B-43F9-A868-136FE4424B32Q34413764-5EEF201C-DB89-4DBB-B614-901D684E3B56Q35216337-224E4F32-1C70-43F0-8E05-D08C2C9DE232Q35217405-E041B616-F2F2-47F2-B1D4-294944FE4328Q35626799-AF6A21A3-EF77-4E37-B518-D647C72AAA6DQ35635538-D3EA4C2E-CBA0-4323-BFDC-0446C93220B2Q35768988-6B14D119-D616-48D8-810C-8A9FA55CF000Q35770277-07488620-8471-4F64-9799-8C551F773B91Q35770626-58945F52-E696-42F9-84B0-4EC975D3ACDDQ35954328-18F3E483-3605-4AC5-9C26-33A3BC66CD1DQ36066276-3241BA3B-EFFD-44DA-A46E-E98D9B33BBFFQ36416358-C4CB79A0-C0C0-4DFB-AA54-E28C5106712FQ36497421-8BE2102E-1B80-467E-9515-6557B852629CQ36621405-E43DA82C-8DD2-4389-BD5D-0A81F31B9FBDQ36655128-B88F6254-AE1B-4260-B496-E0AABFD283B5Q36816162-D9927B55-761A-4B9F-AF27-A9F04080A9A1Q36929658-1A0BCE75-E166-47BF-9E96-32D03A1D9987Q37086937-6F0FAB44-DB8F-4F99-9E69-51310B91F65BQ37104787-400B3B8B-538E-4156-869B-F69E3D35E065Q37184917-6FC87C5D-36B6-4FC7-9A32-1E8DBE3414D7Q37424922-DBC6F374-165F-4E36-9768-BFC2E3BC879AQ37616347-AF14AC1A-3825-442D-9EDB-A00289F3612BQ37706200-6AB6D112-C1CB-4B4A-A22A-98A27F337509Q37962577-59B924B4-B22B-4284-AB23-6CFB3CB7F041Q38020153-FF90C431-C81E-440F-953A-2DE864310243Q38056891-139BD0D3-7414-4C34-821F-4C0C889D58EDQ38059899-3DA82FCC-3716-4BF4-BCAF-846A8F1D96F7Q38084610-E3F70FF5-4262-4890-AC37-E8E1171C6E86Q38251339-DA854782-ABEF-4ED4-A228-AE293E3DDC26Q38255676-B233225D-E8C8-4BD7-B1FB-E6BB676377AFQ38334440-90537086-FA9B-46C9-95A1-807E38360F9FQ38343779-B653FAEA-F005-450A-B0AD-AEF9D03BC80AQ38595057-7B2AE04F-495E-44E9-9EA8-F2ECA860CFACQ38889464-88B554C1-3C15-4E86-956B-65F877B1033BQ38996899-BD8376B0-9B0C-4113-8AFE-9E2424D8BC3FQ39472965-97E2CDBD-3A40-4757-9F89-708EB97C334CQ39745821-B0D87B77-DFC1-4BC9-8429-1FE054DC0F32Q42721337-53A9324D-4B9A-4A01-8D67-9C48B96E0235
P2860
Hypermethylation of gene promoters in hematological neoplasia
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Hypermethylation of gene promoters in hematological neoplasia
@ast
Hypermethylation of gene promoters in hematological neoplasia
@en
Hypermethylation of gene promoters in hematological neoplasia
@nl
type
label
Hypermethylation of gene promoters in hematological neoplasia
@ast
Hypermethylation of gene promoters in hematological neoplasia
@en
Hypermethylation of gene promoters in hematological neoplasia
@nl
prefLabel
Hypermethylation of gene promoters in hematological neoplasia
@ast
Hypermethylation of gene promoters in hematological neoplasia
@en
Hypermethylation of gene promoters in hematological neoplasia
@nl
P356
P1476
Hypermethylation of gene promoters in hematological neoplasia
@en
P2093
P304
P356
10.1002/HON.694
P407
P50
P577
2002-12-01T00:00:00Z